Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Rhinology ; 59(4): 352-359, 2021 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-34180463

RESUMEN

Selecting an appropriate allergen-specific immunotherapy (AIT) regimen for polysensitised allergic rhinitis (AR) patients is challenging for clinicians. Although previous studies showed comparable effectiveness of single-allergen AIT with house dust mite (HDM) extract between monosensitised and polysensitised AR patients, there is no systematic review and meta-analysis demonstrating the comparable effectiveness of HDM AIT. In this meta-analysis, we analysed nine studies to compare the clinical effectiveness of HDM AIT. The primary outcome was nasal symptom score and secondary outcomes were medication and quality of life scores. The changes in nasal symptom score after HDM AIT did not significantly differ between monosensitised and polysensitised patients. The clinical effectiveness of HDM AIT regarding medication and quality of life score was not significantly different between monosensitised and polysensitised patients). In conclusion, single-allergen AIT with HDM extract showed comparable clinical effectiveness between polysensitised and monosensitised patients with AR.


Asunto(s)
Rinitis Alérgica , Inmunoterapia Sublingual , Animales , Desensibilización Inmunológica , Humanos , Pyroglyphidae , Calidad de Vida , Rinitis Alérgica/terapia , Resultado del Tratamiento
2.
Clin Exp Allergy ; 48(3): 253-265, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29288502

RESUMEN

BACKGROUND: Allergic respiratory conditions have been associated with increased susceptibility to viral infection due to impaired interferon (IFN)-related immune responses, but the mechanisms for reinforcement of mucosal immunity against viral infection in allergic diseases are largely unknown. OBJECTIVES: To determine whether IFN induction would be impaired in allergic nasal mucosa and to identify whether higher loads of influenza A virus (IAV) in allergic nasal mucosa could be controlled with IFN treatment. METHODS: Influenza A virus mRNA, viral titres and IFN expression were compared in IAV-infected normal human nasal epithelial (NHNE, N = 10) and allergic rhinitis nasal epithelial (ARNE, N = 10) cells. We used in vivo model of allergic rhinitis (BALB/c mice, N = 10) and human nasal mucosa from healthy volunteers (N = 72) and allergic rhinitis patients (N = 29) to assess the induction of IFNs after IAV infection. RESULTS: Influenza A virus mRNA levels and viral titres were significantly higher in ARNE compared with NHNE cells. IFN-ß and IFN-λs were induced in NHNE and ARNE cells up to 3 days after IAV infection. Interestingly, induction of IFN-λs mRNA levels and the amount of secreted proteins were considerably lower in ARNE cells. The mean IFN-λs mRNA level was also significantly lower in the nasal mucosa of AR patients, and we found that recombinant IFN-λ treatment attenuated viral mRNA levels and viral titres in IAV-infected ARNE cells. In vivoAR mouse exhibited higher viral load after IAV infection, but intranasal inoculation of IFN-λ completely decreased IAV protein expression and viral titre in nasal mucosa of IAV-infected AR mouse. CONCLUSION: Higher susceptibility of the allergic nasal mucosa to IAV may depend on impairment of type III IFN induction, and type III IFN is a key mechanistic link between higher viral loads and control of IAV infection in allergic nasal mucosa.


Asunto(s)
Gripe Humana/inmunología , Interferones/inmunología , Mucosa Nasal/inmunología , Rinitis Alérgica/inmunología , Adulto , Animales , Femenino , Humanos , Virus de la Influenza A/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Persona de Mediana Edad , Mucosa Nasal/virología , Rinitis Alérgica/virología , Carga Viral/inmunología , Adulto Joven , Interferón lambda
3.
Allergy ; 68(7): 862-9, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23751068

RESUMEN

BACKGROUND: Since the recent establishment of a murine model of eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP), both the development of new drugs for treatment or prevention of eosinophilic CRSwNP and elucidation of their pathogenesis have been feasible. We investigated the therapeutic effects of resveratrol on CRSwNP and its mechanism of action using a murine model. METHODS: After induction of eosinophilic CRSwNP, the therapeutic effects of resveratrol were tested and compared with those of triamcinolone acetonide. Histopathologic changes were evaluated using hematoxylin and eosin for overall inflammation, Sirius red for eosinophils, and Masson's trichrome stain for collagen. The expression levels of the interleukin (IL)-4, IL-5, prostaglandin D synthase, and leukotriene C4 synthase genes were assessed by quantitative real-time PCR. Cyclooxygense-2 and 5-lipoxygense levels were evaluated by immunohistochemical staining and Western blot analysis. RESULTS: The degree of eosinophilic infiltration and subepithelial fibrosis was significantly decreased by administration of high-dose resveratrol, the potency of which was similar to that of triamcinolone acetonide. The expression levels of the IL-4, IL-5, prostaglandin D synthase, and leukotriene C4 synthase genes were significantly decreased by administration of low- or high-dose resveratrol. The production of 5-lipoxygenase was strongly inhibited by high-dose resveratrol. CONCLUSIONS: Resveratrol may be useful for the prevention of eosinophilic CRSwNP. A key mechanism of its action is believed to be its anti-inflammatory effect, particularly on eosinophils, by inhibiting the lipoxygenase pathway.


Asunto(s)
Eosinofilia/tratamiento farmacológico , Pólipos Nasales/tratamiento farmacológico , Rinitis/tratamiento farmacológico , Sinusitis/tratamiento farmacológico , Estilbenos/farmacología , Animales , Antiinflamatorios no Esteroideos/farmacología , Biopsia con Aguja , Western Blotting , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Eosinofilia/complicaciones , Eosinofilia/inmunología , Inmunohistoquímica , Ratones , Ratones Endogámicos BALB C , Pólipos Nasales/complicaciones , Pólipos Nasales/patología , Distribución Aleatoria , Reacción en Cadena en Tiempo Real de la Polimerasa , Valores de Referencia , Resveratrol , Rinitis/complicaciones , Rinitis/inmunología , Medición de Riesgo , Sinusitis/complicaciones , Sinusitis/inmunología , Estadísticas no Paramétricas , Resultado del Tratamiento
4.
Rhinology ; 49(3): 309-14, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21858261

RESUMEN

BACKGROUND: Though mucosal cysts in the paranasal sinuses (PSMCs) are common findings on radiographic images, the nature of PSMCs and risk factors for the development of PSMCs have not yet been determined. The aim of this study was to evaluate the characteristics of PSMCs using brain magnetic resonance (MR) imaging. METHODOLOGY/PRINCIPAL: A total of 6831 subjects who underwent health checkup including brain MR imaging were included in this study. The characteristics of PSMCs, including their location, number and size, as well as the presence of obstruction of the sinus ostium and sinusitis, were analysed using brain MR images. Structured questionnaires and medical records were reviewed to evaluate the smoking status and comorbid medical conditions. RESULTS: The overall prevalence of PSMCs was 7.4% and was significantly higher in females than in males. PSMCs were most commonly found in the maxillary sinus, most of which were located unilaterally as a solitary cyst. Large cysts were associated with obstruction of the sinus ostium and subsequent sinusitis. Smoking was a single important risk factor for developing PSMCs. No significant associations were found between symptoms (nasal/respiratory) and the presence of PSMCs. CONCLUSIONS: The prevalence of PSMCs was 7.4% and decreased with age. Large cysts may lead to obstruction of the sinus and subsequent sinusitis. Smoking was an important risk factor for PSMCs, and the total amount of smoking correlated with cyst size. Most subjects were asymptomatic, and specific treatment was not performed.


Asunto(s)
Quistes/epidemiología , Enfermedades de los Senos Paranasales/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Niño , Quistes/patología , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Enfermedades de los Senos Paranasales/patología , Estudios Retrospectivos , Factores de Riesgo , Fumar/epidemiología , Adulto Joven
5.
Allergy ; 66(2): 279-86, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21208219

RESUMEN

BACKGROUND: Tumor necrosis factor (TNF)-α is a principal mediator of the acute inflammatory response, including allergic rhinitis. TNF-α inhibitors are widely used for the treatment of inflammatory conditions such as rheumatoid arthritis and inflammatory bowel diseases; however, the effects of TNF-α inhibitors on allergic rhinitis are not well established. We aimed to investigate the effects of infliximab, a TNF-α inhibitor, on allergic rhinitis in a mouse model. METHODS: BALB/c mice were sensitized with ovalbumin (OVA) and alum, and challenged intranasally with OVA. The TNF-α inhibitor, infliximab was administered intraperitoneally, and multiple parameters of allergic responses were evaluated to determine the effects of infliximab. RESULTS: Infliximab reduced allergic symptoms and eosinophilic infiltration into the nasal mucosa. It also suppressed total and OVA-specific IgE levels, and inhibited local Th2 cytokine transcription in the nasal mucosa and systemic Th2 cytokine production by splenocytes. Furthermore, the expression of E-selectin, neither intercellular adhesion molecule 1 (ICAM-1) nor vascular cell adhesion molecule 1 (VCAM-1), in the nasal mucosa was suppressed in the infliximab-treated group when compared to the nontreated group. CONCLUSION: This study shows that the TNF-α inhibitor infliximab induces anti-allergic effects by decreasing local and systemic Th2 cytokine (IL-4) production, total and OVA-specific IgE levels, adhesion molecule (E-selectin) expression, and eosinophil infiltration into the nasal mucosa in an allergic rhinitis model. Therefore, infliximab should be considered as a potential agent in treating allergic rhinitis.


Asunto(s)
Antialérgicos/farmacología , Anticuerpos Monoclonales/farmacología , Hipersensibilidad/tratamiento farmacológico , Rinitis/tratamiento farmacológico , Animales , Antialérgicos/administración & dosificación , Antialérgicos/uso terapéutico , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/uso terapéutico , Moléculas de Adhesión Celular/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/efectos de los fármacos , Eosinófilos/efectos de los fármacos , Inmunoglobulina E/efectos de los fármacos , Infliximab , Ratones , Ratones Endogámicos BALB C , Mucosa Nasal/inmunología , Ovalbúmina/inmunología , Células Th2/inmunología
6.
Ann Oncol ; 20(8): 1414-9, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19468031

RESUMEN

BACKGROUND: Recent researches revealed that class III beta-tubulin (TUBB3) is a prognostic marker in various tumors and role of TUBB3 in head and neck squamous cell carcinoma (HNSCC) is not defined yet. We analyzed the significance of TUBB3 expression along with p53 and ERCC1 in locally advanced HNSCC patients receiving cisplatin-based induction chemotherapy. MATERIALS AND METHODS: Retrospective review of medical records at Seoul National University Hospital between 1998 and 2007 was carried out. Immunohistochemical stain of TUBB3, p53, and ERCC1 was done in paraffin-embedded tumor tissue. We assessed response to treatment, progression-free survival (PFS), overall survival (OS), and cancer-specific survival (CSS). RESULTS: Eighty-five patients with oropharyngeal, hypopharyngeal, and laryngeal cancers received induction chemotherapy with 5-fluorouracil (5-FU) and cisplatin (n = 55), or 5-FU, cisplatin, and docetaxel (Taxotere) (n = 30). Eighty-three received definitive treatment after induction chemotherapy, where 62 received radiotherapy and 21 received surgery. TUBB3-positive patients showed lower response rate than TUBB3-negative patients (69% versus 88%, P = 0.039). Shorter median PFS was observed in TUBB3-positive group (12 versus 47 months, P = 0.001). Shorter median OS was observed in TUBB-positive group not reaching statistical significance (30 versus 59 months, P = 0.072). TUBB3 status significantly influenced CSS (35 months versus not reached, P = 0.017). Positive p53 status was related to poorer OS and CSS. ERCC1 showed no influence on chemotherapy response, PFS, OS, and CSS. CONCLUSION: TUBB3 is a predictive and prognostic marker along with well-known p53 in HNSCC patients receiving cisplatin-based induction chemotherapy. Clinical impact of ERCC1 is not evident in this setting.


Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Proteínas de Unión al ADN/biosíntesis , Endonucleasas/biosíntesis , Neoplasias de Cabeza y Cuello/metabolismo , Tubulina (Proteína)/biosíntesis , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/biosíntesis , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/enzimología , Cisplatino/administración & dosificación , Supervivencia sin Enfermedad , Docetaxel , Femenino , Fluorouracilo/administración & dosificación , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/enzimología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tasa de Supervivencia , Taxoides/administración & dosificación , Proteína p53 Supresora de Tumor/biosíntesis
7.
Allergy ; 64(1): 118-22, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19120071

RESUMEN

BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSNP) and asthma are inflammatory lesions of the respiratory epithelium. This study was conducted to evaluate predictive factors of bronchial hyperresponsiveness (BHR) in patients with CRSNP. METHODS: BHR was evaluated using a methacholine bronchoprovocation test (MBPT) in 122 consecutive patients newly diagnosed with CRSNP at Seoul National University Hospital from January 2004 to June 2006. The following parameters were analyzed and compared between the BHR and non-BHR groups: symptoms, atopic status, current smoking, disease severity of CRSNP based on the Lund-Mackay scoring system of sinus CT, and counts of eosinophils in the serum and nasal tissues. RESULTS: Thirty-five percent of the patients were found to have BHR, and BHR was found to occur more frequently in patients that were currently suffering from sneezing (P = 0.007). In addition, the mean eosinophil counts of the serum and nasal tissues were higher in the BHR group than in the non-BHR group (P = 0.001 for the serum, P = 0.045 for the nasal tissues), and the eosinophil counts of the serum correlated to those of the nasal tissues (r = 0.334, P = 0.013). The disease severity, as determined by the Lund-Mackay scoring system, was not different between the two groups (P > 0.05). The best cutoff serum eosinophil count for predicting BHR in CRSNP patients was determined to be 300 cells/microl (sensitivity 70%, specificity 70%). CONCLUSION: Taken together, these results indicate that moderate to severe sneezing and a serum eosinophil count > or = 300 cells/microl may be predictive factors for BHR in patients with CRSNP.


Asunto(s)
Hiperreactividad Bronquial/diagnóstico , Pólipos Nasales/complicaciones , Valor Predictivo de las Pruebas , Rinitis/complicaciones , Sinusitis/complicaciones , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Pruebas de Provocación Bronquial , Recuento de Células , Enfermedad Crónica , Eosinófilos/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Estornudo , Adulto Joven
8.
Int J Impot Res ; 20(6): 549-53, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18997807

RESUMEN

Several reports have suggested a high incidence of erectile dysfunction (ED) among patients with obstructive sleep apnea syndrome (OSAS). The aim of this study was to investigate the correlation between OSAS and ED, or disease-specific quality of life (QOL) in patients with OSAS. In addition, we analyzed specific polysomnographic (PSG) parameters in predicting ED in OSAS patients. In total, 32 patients with OSAS and 27 normal controls were asked to complete the Korean versions of the International Index of Erectile Function questionnaire (KIIEF-5) and the Calgary Sleep Apnea Quality of Life Index (SAQLI). All patients then underwent a full-night in-laboratory PSG examination. Patients were diagnosed with OSAS if they had clinical symptoms suggestive of OSAS for at least 1 year and an apnea-hypopnea index (AHI) of more than 10 in PSG. Nineteen patients (59.3%) in the OSAS group showed ED, which was significantly higher than in the control group (8 patients, 29.6%, P=0.012). In addition, SAQLI scores worsened as AHI increased (r=0.327, P=0.011) and as the lowest oxygen saturation level decreased (r=0.420, P=0.001). ED was not significantly correlated with AHI (r=0.061, P=0.649); however, it was significantly correlated with the lowest oxygen saturation decreased (r=0.338, P=0.009). When the cutoff value for the lowest oxygen saturation level to predict ED was set at 77%, its positive predictive value was 88.9% (sensitivity=0.70, specificity=0.62). Thus, all male patients with OSAS should be screened for erectile dysfunction and more comprehensive consultation is needed, especially, if their lowest oxygen saturation levels are below 77%.


Asunto(s)
Disfunción Eréctil/complicaciones , Calidad de Vida , Apnea Obstructiva del Sueño/complicaciones , Adulto , Disfunción Eréctil/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Oxígeno/metabolismo , Polisomnografía , Apnea Obstructiva del Sueño/metabolismo , Encuestas y Cuestionarios
9.
Allergy ; 62(9): 1051-6, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17686108

RESUMEN

BACKGROUND: Subjects with allergic rhinitis but no clinical evidence of asthma have greater bronchial hyperresponsiveness (BHR), and several factors have been implicated as its determinants. However, studies in young children are lacking. The aims of this study were to evaluate the prevalence of BHR in young children with allergic rhinitis and to investigate its risk factors. METHODS: Methacholine bronchial challenges were performed in 4- to 6-year-old nonasthmatic children with allergic rhinitis (n = 83) and in healthy nonatopic controls (n = 32), using a modified auscultation method. The end-point was defined as the appearance of wheezing and/or oxygen desaturation. Subjects were considered to have BHR when they had end-point concentrations of methacholine

Asunto(s)
Hiperreactividad Bronquial/epidemiología , Hipersensibilidad Respiratoria/epidemiología , Rinitis/epidemiología , Alérgenos/efectos adversos , Alérgenos/inmunología , Hiperreactividad Bronquial/sangre , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/fisiopatología , Pruebas de Provocación Bronquial , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/sangre , Masculino , Cloruro de Metacolina/farmacología , Prevalencia , Hipersensibilidad Respiratoria/sangre , Hipersensibilidad Respiratoria/inmunología , Hipersensibilidad Respiratoria/fisiopatología , Rinitis/sangre , Rinitis/inmunología , Rinitis/fisiopatología , Factores de Riesgo , Pruebas Cutáneas
10.
Med Biol Eng Comput ; 41(4): 481-5, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12892373

RESUMEN

Ciliary beating and metachronal waves are fundamental to effective mucociliary transport. The ciliary beat frequencies (CBFs) and metachronal wave directions of multiple cilia beating in culture media were measured simultaneously using digital microscopic images. The degree of synchronisation between ciliary beats was determined by the correlation between ciliary signals at two different locations. The wave propagation directions of cilia were determined from a two-dimensional correlation map by a principal axis method. The standard deviation of measured wave directions in a region of interest was defined as a measure of metachronal wave disorder (MWD). Considerable variation was found in the beat frequencies and metachronal wave directions of cilia beating on epithelium. The pooled mean of MWDs was 23.4 +/- 8.8 degrees, and the pooled mean of CBFs was 10.1 +/- 1.9 Hz on 120 cells from five healthy subjects. The means of the MWD and the CBF from subjects were highly correlated (correlation = -0.83). The higher the CBF, the lower the level of the MWD.


Asunto(s)
Procesamiento de Imagen Asistido por Computador , Depuración Mucociliar , Seno Esfenoidal/fisiología , Humanos , Microscopía por Video , Membrana Mucosa/fisiología
11.
Ann Otol Rhinol Laryngol ; 110(11): 1011-6, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11713910

RESUMEN

This study aimed to determine the characteristics of ciliogenesis and the ciliary beat frequency (CBF) of cultured human nasal epithelial cells by means of an in vitro air-liquid interface (ALI) culture system. On the 14th, 21st, and 27th days of ALI culture, CBFs of cultured cells were measured with a video computerized analysis system, and the epithelial cell-collagen matrix complex was examined by scanning and transmission electron microscopy. Using a CBF distribution map, we calculated the proportion of ciliary beating area (CBA) on the cultured cells. On the 14th day, ciliated cells could be easily distinguished from other cells on scanning electron microscopy by their elongated cilia. Between the 14th and 27th days, the number of mature cilia increased, and after 27 days of air exposure, the cilia of each cell pointed to one direction. From the beginning of air-exposure culture until the 7th day, the number of secretory cells increased; however, from the 7th day to the 27th day, it decreased, and the number of ciliated cells increased. Total CBAs increased from the 7th day to the 21st day. The proportions of actively beating cells and the mean CBFs of beating cells among cultured epithelial cells increased with culture time. On the 21st day, the mean CBF of the cultured cells was similar to that of nasal ciliated cells in biopsy specimens (10.9 +/- 0.5 Hz versus 11.4 +/- 1.3 Hz), but until the 27th day, the CBF of cultured cells increased significantly (13.9 +/- 0.8 Hz). It is suggested that there may be some difference in CBF between nasal epithelial cells submitted to biopsy and nasal epithelial cells cultured by the ALI culture system.


Asunto(s)
Cilios/fisiología , Depuración Mucociliar/fisiología , Mucosa Nasal/citología , Células Cultivadas , Cilios/patología , Células Epiteliales , Humanos , Procesamiento de Imagen Asistido por Computador , Técnicas In Vitro , Microscopía Electrónica de Transmisión de Rastreo , Mucosa Nasal/patología , Estadísticas no Paramétricas , Factores de Tiempo
12.
Otolaryngol Head Neck Surg ; 124(3): 313-6, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11240998

RESUMEN

Various saline solution formulae are frequently used in patients with rhinosinusitis. Osmolarity affects ciliary beat frequency (CBF); however, little is known about the effects of saline solutions on ciliary activity of nasal epithelial cells. The aim of this study was to assess whether CBF of normal turbinate mucosa is affected by hypertonic, isotonic, or hypotonic saline solution in vitro and whether histologic changes are associated with the alteration of ciliary movement. We assessed variations of CBF after exposure to 0.06%, 0.12%, 0.9%, 3.0%, or 7.0% saline solutions and histologic changes were examined by transmission electron microscopy. Isotonic and hypotonic solutions produced no ciliary slowing; however, ciliostasis was observed within a few minutes in 3.0% or 7.0% solution. The histologic changes demonstrated that the ciliary slowing might be attributed to epithelial damage by fluid transport toward the surrounding medium. In conclusion, hypertonic saline solutions decrease CBF and disrupt nasal epithelial cells in vitro.


Asunto(s)
Mucosa Nasal/efectos de los fármacos , Solución Salina Hipertónica/farmacología , Técnicas de Cultivo de Célula , Humanos , Soluciones Hipotónicas/farmacología , Soluciones Isotónicas/farmacología , Masculino , Microscopía Electrónica , Depuración Mucociliar/efectos de los fármacos , Mucosa Nasal/ultraestructura , Factores de Tiempo
14.
Laryngoscope ; 111(2): 246-50, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11210869

RESUMEN

OBJECTIVES: This study was performed to investigate the changes in ciliary beat frequency (CBF) after treatment with Larginine in the human sinus mucosa and to determine the distribution of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) in the healthy sinus mucosa. STUDY DESIGN/METHODS: CBF was measured in the sphenoid sinus mucosa of 12 patients who underwent trans-septal trans-sphenoidal hypophysectomy for the treatment of pituitary gland tumor. CBF was measured over 24 hours in Dulbecco's modified Eagle's medium (DMEM) after treatment with L-arginine, its inactive spatial isomer D-arginine, or an NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME). DMEM without treatment with these materials was used as a control. Other pieces of the mucosa were exposed to L-NAME and its inactive spatial isomer D-NAME after preincubation with L-arginine. The specimens were immunohistochemically stained for iNOS and eNOS. RESULTS: CBF increased 24 hours after treatment with L-arginine as compared with control groups. CBF increased in proportion to the increasing concentrations of L-arginine. There was no significant change after treatment with D-arginine or L-NAME. CBF increased after treatment with L-arginine at 30 minutes and maintained for 24 hours. L-NAME inhibited the increase in CBF by L-arginine, but D-NAME showed no such effect. Immunoreactivity to both iNOS and eNOS was frequently observed in the ciliated epithelial cells and was stronger to eNOS than to iNOS. CONCLUSIONS: From the results of this study it is suggested that nitric oxide (NO) produced by iNOS and eNOS using L-arginine may increase CBF in the healthy sinus mucosa and that NO may have a regulatory function in ciliary motility in the human sinus mucosa.


Asunto(s)
Depuración Mucociliar/fisiología , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico/fisiología , Mucosa Respiratoria/enzimología , Inducción Enzimática/fisiología , Humanos , Técnicas para Inmunoenzimas , Mucosa Nasal/enzimología , Valores de Referencia
15.
Laryngoscope ; 111(1): 153-8, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11192885

RESUMEN

OBJECTIVES: Temperature-controlled and temperature-monitored radiofrequency tissue volume reduction (RFTVR) for the turbinate is a new treatment modality for nasal obstruction secondary to turbinate hypertrophy. We compared the nasal functions after the treatment ofRFTVR and laser vaporizing turbinoplasty (LVT) using subjective symptom scores and objective tests. STUDY DESIGN: Prospective, randomized clinical trial. METHODS: Twenty-four patients with nasal obstruction secondary to inferior turbinate hypertrophy were prospectively evaluated from March 1999 to October 1999 at Seoul National University Hospital (Seoul, Korea). Sixteen patients were treated with RFTVR, and eight patients with LVT. The preoperative and postoperative nasal functions were investigated by visual analogue scale of symptoms, butanol threshold test, saccharine test, acoustic rhinometry, rhinomanometry, and ciliary beat frequency. RESULTS: At 8 weeks postoperatively, the severity and the frequency of nasal obstruction improved subjectively in 81.3% and 93.8% of RFTVR group and in 87.5% and 87.5% of LVT group, respectively. Significant improvement of nasal symptoms began from 2 to 3 days after the operation in the RFTVR group, whereas there was significant improvement of nasal symptoms at 8 weeks after operation in the LVT group. However, objective nasal functions including nasal volume and total nasal resistance were significantly improved at 8 weeks after surgery in both groups. Among patients reporting symptoms of hyposmia, 55.6% of RFTVR group and 63.6% of LVT group showed improved olfaction. Saccharin transit time and ciliary beat frequency were preserved after RFTVR CONCLUSION: RFTVR for the turbinate may be useful as an alternative approach for the treatment of chronic turbinate hypertrophy.


Asunto(s)
Ablación por Catéter , Obstrucción Nasal/cirugía , Nariz/fisiopatología , Cornetes Nasales/cirugía , Acústica , Adulto , Resistencia de las Vías Respiratorias/fisiología , Butanoles , Ablación por Catéter/instrumentación , Ablación por Catéter/métodos , Cilios/fisiología , Femenino , Estudios de Seguimiento , Humanos , Hipertrofia , Terapia por Láser/métodos , Masculino , Manometría , Depuración Mucociliar/fisiología , Cavidad Nasal/patología , Mucosa Nasal/fisiopatología , Obstrucción Nasal/patología , Obstrucción Nasal/fisiopatología , Odorantes , Trastornos del Olfato/fisiopatología , Satisfacción del Paciente , Estudios Prospectivos , Reoperación , Sacarina , Umbral Sensorial/fisiología , Olfato/fisiología , Estadísticas no Paramétricas , Temperatura
16.
Ann Otol Rhinol Laryngol ; 109(5): 484-7, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10823478

RESUMEN

Macrolide antibiotics have a variety of actions along with antimicrobial action. To determine the effects of oral administration of clarithromycin (CAM) on rheological properties, we measured the spinability, dynamic viscoelasticity, and solid composition of human nasal mucus from 18 patients with chronic sinusitis before and after administration of CAM for 4 weeks. After administration of CAM, the spinability and percent solid composition of nasal mucus increased from 26.5 +/- 12.2 mm to 40.2 +/- 18.7 mm and 7.86% +/- 3.47% to 13.90% +/- 3.67% (p < .05), respectively, whereas the ratio of the viscosity to the elasticity (eta'/G') of nasal mucus after the administration of CAM decreased in all of the mucus samples. These results suggest that treatment with CAM may modulate the rheological properties of nasal mucus in patients with chronic sinusitis.


Asunto(s)
Antibacterianos/farmacología , Claritromicina/farmacología , Mucosa Nasal/efectos de los fármacos , Sinusitis/tratamiento farmacológico , Adolescente , Adulto , Antibacterianos/uso terapéutico , Enfermedad Crónica , Claritromicina/uso terapéutico , Elasticidad/efectos de los fármacos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Reología/efectos de los fármacos , Resultado del Tratamiento , Viscosidad/efectos de los fármacos
17.
Am J Rhinol ; 13(5): 339-43, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10582110

RESUMEN

This study aimed to investigate expression of various cytokine mRNAs, including IL-6, IL-8, TGF-beta, IL-4, IL-5, and IFN-gamma in maxillary sinus mucosa of patients with chronic sinusitis. Maxillary sinus mucosae of six patients with chronic sinusitis and turbinate mucosae of six healthy subjects were obtained. We performed RT-PCR and Southern blot to examine gene expression of the cytokines IL-6, IL-8, TGF-beta, IL-4, IL-5, and IFN-gamma in maxillary sinus mucosa and compared the results with cytokine gene expressions in normal turbinate mucosa. IL-6, IL-8, TGF-beta, IL-4, IL-5, and IFN-gamma mRNAs were expressed more frequently in maxillary sinus mucosa from patients with chronic sinusitis than in normal turbinate mucosa. All the maxillary sinus mucosa specimens revealed relatively higher mean density ratio for each cytokine investigated than did normal turbinate mucosa. IL-6, IL-8, TGF-beta, IL-4, IL-5, and IFN-gamma mRNAs were expressed simultaneously in maxillary sinus mucosa of chronic sinusitis. These cytokines may be responsible for recruitment of inflammatory cells and for mucosal thickening in chronic sinusitis, and thus chronicity of the disease.


Asunto(s)
Regulación de la Expresión Génica/inmunología , Interferón gamma/análisis , Interleucinas/análisis , Seno Maxilar/inmunología , Sinusitis Maxilar/inmunología , Factor de Crecimiento Transformador beta/análisis , Adulto , Secuencia de Bases , Enfermedad Crónica , Cartilla de ADN , Femenino , Humanos , Masculino , Seno Maxilar/química , Sinusitis Maxilar/etiología , Persona de Mediana Edad , Datos de Secuencia Molecular , Membrana Mucosa/química , Membrana Mucosa/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/estadística & datos numéricos , Cornetes Nasales/química , Cornetes Nasales/inmunología
18.
Laryngoscope ; 109(12): 2021-4, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10591367

RESUMEN

OBJECTIVE: The in vitro effects of staphylococcal alpha-toxin on ciliary activity were investigated at different concentrations and exposure times. STUDY DESIGN: Ciliated epithelial cells of the sphenoid sinus were taken from patients operated on for pituitary tumors. Video-computerized analysis technique and transmission electron microscopy were used to analyze the effects of the toxin on ciliary activity. METHODS: Ciliary beat frequency (CBF) was measured in four different concentrations of alpha-toxin including 0.1, 1, 10, and 50 microg/mL. CBF was measured at 2, 4, 6, 12, 24, and 48 hours after administration of the toxin. To observe reversibility of the reduced ciliary activity, after 24-hour incubation in the media containing 10 microg/mL of alpha-toxin, the media were replaced with alpha-toxin-free media. The tissues were also processed for transmission electron microscopy to observe ultrastructural changes of the epithelial cells. RESULTS: CBF increased significantly at 2-hour incubation and then decreased significantly after 12-hour incubation in 10 microg/mL of alpha-toxin (P< .05, repeated-measures ANOVA). The transmission electron microscopic findings showed mitochondrial swelling and a slight protrusion of the plasma membrane of the cilia. In toxin-free media, loss of ciliary activity was not recovered. CONCLUSIONS: CBF increased at first, but with increasing incubation time ciliary movements decreased gradually and stopped eventually. This loss of CBF may be an irreversible change associated with ultrastructural changes in the mitochondria and the plasma membrane of the cilia.


Asunto(s)
Toxinas Bacterianas/farmacología , Células Epiteliales/efectos de los fármacos , Proteínas Hemolisinas/farmacología , Depuración Mucociliar/efectos de los fármacos , Mucosa Nasal/efectos de los fármacos , Staphylococcus aureus/patogenicidad , Células Cultivadas , Células Epiteliales/patología , Humanos , Microscopía Electrónica , Mucosa Nasal/patología
20.
Ann Otol Rhinol Laryngol ; 108(6): 594-8, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10378529

RESUMEN

Eosinophil-chemoattracting cytokines are thought to be important in the pathogenesis of allergic inflammation. However, little is known about the presence and significance of RANTES in nasal allergy and nasal polyps, two well-known rhinologic disorders characterized by eosinophil infiltration in the tissue. In order to evaluate the role of RANTES in eosinophil infiltration in vivo, the tissue distributions of RANTES and interleukin-5 (IL-5) and their correlation with eosinophil infiltration were investigated. Nasal mucosa specimens were obtained from 9 allergic and 12 control subjects, and nasal polyps from 6 allergic and 9 nonallergic subjects. All the subjects were divided into 4 groups: normal mucosa, allergic mucosa, nonallergic polyps, and allergic polyps. To identify the cellular localizations of RANTES and IL-5, we used specific immunohistochemical staining. We also investigated the differences in cytokine expression among the 4 groups, and the correlation between cytokine expression and eosinophil infiltration in the tissue. RANTES was expressed in the epithelium, endothelium, and some submucosal cells, while IL-5 was confined to the cells in the submucosa. Expression of both RANTES and IL-5 significantly increased in allergic mucosa and nasal polyps compared to normal mucosa; however, there was no significant difference in their expression between allergic and nonallergic polyps. Both cytokines had a significant correlation between their expression and either total or activated eosinophil numbers. The results of this study suggest that RANTES, as well as IL-5, plays a role in eosinophil recruitment in allergic nasal mucosa and nasal polyps in vivo.


Asunto(s)
Quimiocina CCL5/metabolismo , Interleucina-5/metabolismo , Mucosa Nasal/metabolismo , Mucosa Nasal/patología , Pólipos Nasales/metabolismo , Pólipos Nasales/patología , Rinitis Alérgica Perenne/metabolismo , Rinitis Alérgica Perenne/patología , Anticuerpos Monoclonales/inmunología , Quimiocina CCL5/inmunología , Endotelio/inmunología , Endotelio/metabolismo , Eosinófilos/metabolismo , Factor VIII/inmunología , Factor VIII/metabolismo , Humanos , Interleucina-5/inmunología , Mucosa Nasal/inmunología , Pólipos Nasales/complicaciones , Rinitis Alérgica Perenne/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA